Literature DB >> 10554431

Vitiligo: clinical findings in 1436 patients.

S Handa1, I Kaur.   

Abstract

We retrospectively analyzed the clinical and epidemiological profiles of patients with vitiligo attending the pigmentary dermatoses clinic. One thousand four hundred and thirty-six patients were seen between 1989 and 1993. Males constituted 54.5% of the group and females 45.5%. Mean age of the patients was 25 years, and average disease duration at the time of hospital visit was 3.7 years. Vitiligo vulgaris was the commonest form of the disease in 1002 (69.8%) patients followed by focal vitiligo in 214 (14.9%) and segmental vitiligo in 72 (5.0%). The sites of onset were the face, trunk, and legs in descending order of frequency. Less than 20% body area involvement was seen in 1356 (94.4%) of the patients. Leukotrichia was present in 165 (11.5%), and Koebner's phenomenon was observed in 72 (5.0%). Twenty nine (2.0%) patients had associated halo nevi. Of the various diseases associated with vitiligo, atopic/nummular eczema was seen in 20 (1.4%) patients, bronchial asthma in 10 (0.7%), diabetes mellitus in 8 (0.6%), thyroid disease in 7 (0.5%), and alopecia in 6 (0.4%). A family history of vitiligo was present in 165 (11.5%) patients.

Entities:  

Mesh:

Year:  1999        PMID: 10554431     DOI: 10.1111/j.1346-8138.1999.tb02067.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  29 in total

Review 1.  Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.

Authors:  Richard A Spritz
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

2.  Evaluation of Histologically and Histochemically Proven Cases of Vitiligo and its Correlation with CD4+ and CD8+ Lymphocyte Counts using Flow Cytometry.

Authors:  Moninder Kaur; Permeet Kaur Bagga; Tejinder Kaur; Amarjit Singh Kataria
Journal:  J Clin Diagn Res       Date:  2017-05-01

3.  CTLA-4 A49G gene polymorphism is not associated with vitiligo in South Indian population.

Authors:  Farha Deeba; Rabbani Syed; Jariya Quareen; M A Waheed; Kaiser Jamil; Hanmanth Rao
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

Review 4.  The Role of the NKG2D in Vitiligo.

Authors:  Lourdes Plaza-Rojas; José A Guevara-Patiño
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

5.  When are laboratory tests indicated in patients with vitiligo?

Authors:  Marina Rodríguez-Martín; Miguel Sáez; Nayra Merino de Paz; Patricia Contreras Ferrer; Mar Pestana Eliche; Beatriz Rodríguez-Martín; Antonio Noda Cabrera
Journal:  Dermatoendocrinol       Date:  2012-01-01

6.  Oxidative stress in experimental vitiligo C57BL/6 mice.

Authors:  Akrem Jalel; Mrabet Yassine; Mohamed Hédi Hamdaoui
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

7.  Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.

Authors:  Randal K Gregg; Lisa Nichols; Yiming Chen; Bao Lu; Victor H Engelhard
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

8.  Acute toxicity and the 28-day repeated dose study of a Siddha medicine Nuna Kadugu in rats.

Authors:  Ramaswamy Selvaratnam Ramaswamy; Nettam Prathyusha; Ruthiramoorthi Saranya; Haridass Sumathy; Kutuva Tulasi Mohanavalli; Raju Jyothi Priya; Jayakothanda Ramaswamy Venkhatesh; Chidambaram Saravana Babu; Kumarasamy Manickavasakam; Sadagopan Thanikachalam
Journal:  BMC Complement Altern Med       Date:  2012-10-22       Impact factor: 3.659

9.  Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinent.

Authors:  Stanca A Birlea; Fridoon J Ahmad; Raza M Uddin; Shakil Ahmad; Sabrina S Pal; Rasheedunnisa Begum; Naresh C Laddha; Mitesh Dwivedi; Mohmmad Shoab Mansuri; Ying Jin; Katherine Gowan; Sheri L Riccardi; Paulene J Holland; Songtao Ben; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2013-01-10       Impact factor: 8.551

10.  Childhood vitiligo: treatment paradigms.

Authors:  Amrinder Jit Kanwar; M Sendhil Kumaran
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.